Linxiang Cai
State Key Laboratory Of Pharmaceutical Biotechnology
Nanjing, 210023, China
Nanjing, 210023, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Platinum-Paeonol Complexes as ERK Inhibitors To Restrain Melanoma and Relieve Cancer Pain.
Journal: Journal of medicinal chemistry
Published: March 24, 2026
Pt-seq unveils the genomic binding pattern of platinum-based drugs.
Journal: Science advances
Published: October 29, 2025
Platinum(IV) Complexes Trigger Death Receptors and Natural Killer Cells to Suppress Breast Cancer.
Journal: Journal of medicinal chemistry
Published: January 31, 2025
Self-Assembly of Short Peptides Activates Specific ER-Phagy and Induces Pyroptosis for Enhanced Tumor Immunotherapy.
Journal: Angewandte Chemie (International ed. in English)
Published: November 24, 2024
Agonists and Inhibitors of the cGAS-STING Pathway.
Journal: Molecules (Basel, Switzerland)
Published: May 31, 2024
Platinum(IV) Complexes as Inhibitors of STAT3 and Regulators of the Tumor Microenvironment To Control Breast Cancer.
Journal: Journal of medicinal chemistry
Published: August 14, 2023
Overcoming Cancer Resistance to Platinum Drugs by Inhibiting Cholesterol Metabolism.
Journal: Angewandte Chemie (International ed. in English)
Published: June 27, 2023
Platinum-Based TREM2 Inhibitor Suppresses Tumors by Remodeling the Immunosuppressive Microenvironment.
Journal: Angewandte Chemie (International ed. in English)
Published: September 09, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026